Abstract
Treatment failures are common in patients infected with metronidazole-resistant Helicobacter pylori in the gastric mucosa when triple therapy including metronidazole is used. In patients with treatment failure and metronidazole-resistant H. pylori, a higher eradication rate for H. pylori was found after secondary treatment with bismuth/ranitidine in combination with antibiotics including metronidazole, compared with the same antibiotics combined with a standard dose of omeprazole. This agrees with our previous finding that bismuth was able to reduce the susceptibility of H. pylori to metronidazole. In this study, we have found that nizatidine, an H(2)-receptor antagonist, is also able to reduce the susceptibility of H. pylori to metronidazole in vitro, despite having no direct inhibitory effect on the growth of H. pylori. This agrees with earlier findings that compounds having the ability to reverse antibiotic resistance do not necessarily have an antibiotic or chemotherapeutic effect in the sense of growth inhibition. Therefore, it was decided to investigate the effect of nizatidine and omeprazole on the oxidative respiratory chain, as it is known that metronidazole is able to inhibit the activity of fumarate reductase of H. p...Continue Reading
References
Aug 1, 1992·The Journal of Urology·Y ReinbergR Gonzalez
Jun 22, 1991·Lancet·P D KleinE O Smith
Mar 1, 1991·Antimicrobial Agents and Chemotherapy·T IwahiA Imada
Aug 1, 1989·Journal of Clinical Microbiology·F MégraudD Q Hoa
Apr 1, 1989·Pharmacology & Toxicology·J E KristiansenL P Andersen
Jan 1, 1989·Scandinavian Journal of Gastroenterology·T U KosunenG Myllylä
Jun 1, 1988·European Journal of Epidemiology·Y GlupczynskiA Burette
Jun 16, 1984·Lancet·B J Marshall, J R Warren
Aug 1, 1995·Antimicrobial Agents and Chemotherapy·W A Belli, J Fryklund
Aug 1, 1995·Archives of Biochemistry and Biophysics·G L MendzS Srinivasan
Apr 1, 1995·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·M Buckley, C O'Morain
Mar 1, 1996·Gastroenterology·J LabenzA L Blum
Jun 1, 1996·American Journal of Epidemiology·L P AndersenT Jørgensen
Oct 23, 1997·Clinical Microbiology Reviews·B E DunnM J Blaser
Oct 24, 1997·The Journal of Antimicrobial Chemotherapy·J E Kristiansen, L Amaral
Jun 23, 1999·FEMS Immunology and Medical Microbiology·M ChenA Kharazmi
Apr 25, 2000·International Journal of Antimicrobial Agents·L Amaral, J E Kristiansen
Apr 25, 2000·International Journal of Antimicrobial Agents·L P AndersenJ E Kristiansen
Feb 24, 2001·Gastroenterology Clinics of North America·H Cohen
Citations
Dec 22, 2005·The Biochemical Journal·Mauro MileniC Roy D Lancaster
Apr 4, 2007·The Journal of Antimicrobial Chemotherapy·Jette E KristiansenHendrik Keyzer
Feb 6, 2003·International Journal of Biological Macromolecules·P ChristakopoulosH Skaltsa